Peak Bio, Inc. Operating Margin
- Operating margin · 12 months: Value -8290.88%; Formula and calculation Operating income / revenue. Period ending 2024-09-30..
Operating margin
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -8290.88% | Operating income / revenue. Period ending 2024-09-30. $-6.23M ÷ $75.19K × 100 ≈ -8290.88% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -6.23M USD | Operating Income (Loss) |
| Revenue | 75.19K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 281.27K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2024-09-30 | $-6.23M | $75.19K | (m) | $281.27K | (m) | -8290.88% |
| 2024-06-30 | $-6.77M | $354.02K | (m) | $722.04K | (m) | -1913.08% |
| 2024-03-31 | $-8.05M | $354.02K | (m) | $984.55K | (m) | -2274.52% |
| 2023-12-31 | $-13.07M | $367.88K | (m) | $1.63M | (m) | -3551.62% |
| 2023-09-30 | $-17.13M | $553.95K | (m) | $2.12M | (m) | -3091.84% |
| 2023-06-30 | $-16.78M | $467.67K | (m) | $2.43M | (m) | -3588.49% |
| 2023-03-31 | $-16.74M | $568.59K | (m) | $3.23M | (m) | -2944.13% |
| 2022-12-31 | $-11.85M | $607.68K | (m) | $3.92M | (m) | -1949.68% |
| 2022-09-30 | $-15.29M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-13.71M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $-11.19M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-9.07M | $528.31K | (m) | $7.12M | (m) | -1715.95% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.